cobalt has been researched along with h 89 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hsu, CI; Rao, SD; Sorkin, LS; Weiss, JH; Yin, HZ; Yu, S | 1 |
Bruzzese, L; By, Y; Condo, J; Durand-Gorde, JM; Fenouillet, E; Fromonot, J; Guieu, R; Kipson, N; Ruf, J | 1 |
Bertagna, NB; Cruz, FC; Dos Santos, PGC; Fernandes, GJD; Miguel, TT; Queiroz, RM | 1 |
3 other study(ies) available for cobalt and h 89
Article | Year |
---|---|
TNF-α triggers rapid membrane insertion of Ca(2+) permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury.
Topics: Age Factors; Animals; Calcium; Cobalt; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agents; Female; Isoquinolines; Kainic Acid; Motor Neurons; Neurofilament Proteins; Organ Culture Techniques; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Spinal Cord; Sulfonamides; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Cell Hypoxia; Cell Survival; Cells, Cultured; Cobalt; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppression Therapy; Isoquinolines; NF-kappa B; Receptor, Adenosine A2A; Signal Transduction; Sulfites; Sulfonamides; T-Lymphocytes; Triazines; Triazoles; Up-Regulation | 2014 |
Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway.
Topics: Aminopyridines; Animals; Anxiety; Behavior, Animal; Cobalt; Cyclic AMP-Dependent Protein Kinases; Hippocampus; Isoquinolines; Male; Maze Learning; Mice; Microinjections; Motor Activity; Protein Kinase Inhibitors; Receptors, Corticotropin-Releasing Hormone; Signal Transduction; Sulfonamides | 2021 |